During the past decade, Sana Klinikum Offenbach conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 5 clinical trials were completed, i.e. on average, 17.9% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sana Klinikum Offenbach" #1 sponsor was "Sana Klinikum Offenbach" with 5 trials, followed by "German Breast Group" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored, "Aesculap AG" with 2 trials sponsored and "Michael Hopp" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sana Klinikum Offenbach" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "AMC Wolfartklinik Gräfelfing" with 1 trials as a collaborator and "AOK Bayern" with 1 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Sana Klinikum Offenbach" are "Ovarian Cancer" (7 trials), "Breast Cancer" (4 trials), "Obesity" (3 trials), "Metastatic Breast Cancer" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Sana Klinikum Offenbach" in a lesser frequency.

Most popular intervention types in "Sana Klinikum Offenbach" are "Drug" (27 trials), "Other" (7 trials), "Device" (6 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "Rituximab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sana Klinikum Offenbach" are 26 trials for "All" genders, 14 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sana Klinikum Offenbach". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Sana Klinikum Offenbach, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sana Klinikum Offenbach, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".